Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daichi Sadato

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
International Journal of Hematology|October 25, 2024
Quizartinib with donor lymphocyte infusion for post-transplant relapse of FLT3-ITD-positive acute myeloid leukemiaFumihiko Ouchi, Naoki Shingai, Yuho Najima, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|August 4, 2022
[Klinefelter's syndrome diagnosed at the onset of acute myeloid leukemia with inv (16) following treatment for germ cell tumor]Kisa Tanabe, Yuho Najima, Takuhiko Inokuchi, et al.
Leukemia Research|April 30, 2025
Pre-transplant blinatumomab and/or inotuzumab ozogamicin therapy for relapsed/refractory acute lymphoblastic and B/myeloid mixed phenotype acute leukemia in adultsKaori Kondo, Yuho Najima, Daichi Sadato, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|May 13, 2026
[Clinical outcomes of idecabtagene vicleucel therapy for relapsed/refractory multiple myeloma: a single-center retrospective analysis]Kairi Kojo, Yuho Najima, Kyoko Haraguchi, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|March 6, 2024
[FLT3-ITD mutation-positive acute myeloid leukemia undergoing clonal transition with PTPN11 mutation at relapse]Kazuya Kurihara, Daichi Sadato, Yuho Najima, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
International Journal of Hematology|October 25, 2024
Quizartinib with donor lymphocyte infusion for post-transplant relapse of FLT3-ITD-positive acute myeloid leukemiaFumihiko Ouchi, Naoki Shingai, Yuho Najima, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|August 4, 2022
[Klinefelter's syndrome diagnosed at the onset of acute myeloid leukemia with inv (16) following treatment for germ cell tumor]Kisa Tanabe, Yuho Najima, Takuhiko Inokuchi, et al.
Leukemia Research|April 30, 2025
Pre-transplant blinatumomab and/or inotuzumab ozogamicin therapy for relapsed/refractory acute lymphoblastic and B/myeloid mixed phenotype acute leukemia in adultsKaori Kondo, Yuho Najima, Daichi Sadato, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|May 13, 2026
[Clinical outcomes of idecabtagene vicleucel therapy for relapsed/refractory multiple myeloma: a single-center retrospective analysis]Kairi Kojo, Yuho Najima, Kyoko Haraguchi, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|March 6, 2024
[FLT3-ITD mutation-positive acute myeloid leukemia undergoing clonal transition with PTPN11 mutation at relapse]Kazuya Kurihara, Daichi Sadato, Yuho Najima, et al.
Pageof 5